Skip to content

Investigation of Embryoscopy in Recurrent Pregnancy Loss

Investigation of Embryoscopy in Recurrent Pregnancy Loss

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00589446
Enrollment
20
Registered
2008-01-09
Start date
2006-01-31
Completion date
2009-01-31
Last updated
2009-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Miscarriage

Keywords

Embryoscopy, recurrent miscarriage, missed abortion, Structural anomalies in recurrent miscarriage, Embryoscopically directed biopsy for karyotyping

Brief summary

The purpose is to test the value of embryoscopy in women with missed abortions after recurrent miscarriages (at least two previous miscarriages) in the past. This project will assess two functions of embryoscopy:- 1. Whether embryoscopy allows the diagnosis of structural anomalies (disorganized embryos). This is a fetal cause of embryo loss which cannot be diagnosed by other means. 2. Whether embryoscopy allows an accurate biopsy of embryonic tissue for karyotyping. However, it may be that embryoscopy will be found to have no advantage.

Detailed description

In this project, embryoscopy will be evaluated in women with missed abortions (pregnancies which have ceased developing and in which the embryo is dead), after at least two previous (recurrent) miscarriages. The procedure will have two main purposes:- To allow the diagnosis of structural anomalies (disorganized embryos), and to allow an accurate biopsy of embryonic tissue for karyotyping. Hence, this procedure will lead to a more accurate diagnosis of the cause of recurrent miscarriage. After confirmation of missed abortion by ultrasound, dilatation and curettage (D&C) is normally performed under general anesthetic to evacuate the uterus in missed abortions. In this project embryoscopy will be added to the standard D&C. An 8mm hysteroscope with irrigation channel and 300 view will be used with continuous saline flow. The embryo will be visualized, and the findings recorded. Biopsies will be taken for chromosomal analysis from the embryo and the placental villi. Embryoscopy will be performed with a hysteroscope which is in normal clinical use for investigating the uterine cavity, but for a slightly different indication. The first stage will be a pilot study on 20 patients to judge the value of embryoscopy.

Interventions

An 8mm hysteroscope with irrigation channel and 30 degree view will be inserted into the uterus prior to curettage in cases of recurrent missed abortion

Sponsors

Herzliya Medical Center
CollaboratorOTHER
Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Recurrent miscarriage, (at least 2 consecutive miscarriages) * Confirmation of missed abortion by ultrasound * At least 5 1/2 weeks of gestation * D & C is clinically indicated

Exclusion criteria

* Sporadic miscarriages * Less than two consecutive miscarriages. * If D & C is not clinically indicated

Design outcomes

Primary

MeasureTime frame
To test the value of embryoscopy in women with missed abortions after recurrent miscarriagesYearly

Secondary

MeasureTime frame
Whether embryoscopy allows the diagnosis of structural anomaliesAnnual
Whether embryoscopy allows an accurate biopsy of embryonic tissue for karyotyping.Annual

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026